Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Evgen Pharma targets cancer stem cells to reverse the resistance to hormone treatment seen in ER+ breast cancer
January 15, 2018 Off

Evgen Pharma targets cancer stem cells to reverse the resistance to hormone treatment seen in ER+ breast cancer

By Dino Mustafić

Evgen Pharma, a clinical stage drug development company focused on cancer and neurological conditions, will showcase the results of mechanistic…

TiGenix’s Chron disease treatment get further validation
January 15, 2018 Off

TiGenix’s Chron disease treatment get further validation

By Dino Mustafić

TiGenix’s result from study of Xx601 treatment for Chron’s disease has also been published in one of the leading scientific…

Shire can market in EU Adynovi for certain hemophilia A patients
January 15, 2018 Off

Shire can market in EU Adynovi for certain hemophilia A patients

By Dino Mustafić

The European Commission (EC) has given Shire’s ADYNOVI a green light as an extended half-life recombinant factor VIII (rFVIII) treatment…

Hikma adds new scientific and research head
January 15, 2018 Off

Hikma adds new scientific and research head

By Dino Mustafić

Hikma Pharmaceuticals will add Surendera Tyagi as Group Chief Scientific Officer and Global Head of Research and Development, who will…

Sinclair posts strong final quarter 2017, sales up 20%
January 15, 2018 Off

Sinclair posts strong final quarter 2017, sales up 20%

By Dino Mustafić

Sinclair pharma has reported revenue growth in excess of 80% over the last two years will, as expected, return the…

FDA OKs first treatment for breast cancer with a certain inherited genetic mutation
January 12, 2018 Off

FDA OKs first treatment for breast cancer with a certain inherited genetic mutation

By Dino Mustafić

The FDA has expanded the use of AstraZeneca’s Lynparza, the treatment for certain types of breast cancer patients, making it the…

Cash injection to Teva as it settles with Alder in European patent and global license agreement
January 12, 2018 Off

Cash injection to Teva as it settles with Alder in European patent and global license agreement

By Dino Mustafić

Teva and AlderBiopharmaceuticals have entered into a European patent settlement and global license agreement with Teva Pharmaceuticals International GmbH, the new subsidiary of Teva Pharmaceutical Industries.

The agreement resolves Alder’s appeal following

FDA warns BD about flaws in lead testing issues
January 11, 2018 Off

FDA warns BD about flaws in lead testing issues

By Dino Mustafić

The U.S. Food and Drug Administration said Thursday it has warned Becton Dickinson (BD) about several violations of federal law. BD…

Novartis appoints new Oncology CEO
January 11, 2018 Off

Novartis appoints new Oncology CEO

By Dino Mustafić

Novartis has appointed Elizabeth Barrett, currently Global President Oncology at Pfizer, Inc., as the CEO Novartis Oncology and a member…

January 11, 2018 Off

Advanced biotech startup touts ground-breaking medical research, deep ties to New York State

By Dino Mustafić

Hemogenyx Pharmaceuticals, the biotechnology company developing novel therapies to transform bone marrow, or blood stem cell, transplantation for the treatment…

Posts pagination

Previous 1 … 3,415 3,416 3,417 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine